B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer.

B-MYB belongs to the MYB family of transcription factors that include A-MYB and c-MYB. While A-MYB and c-MYB are tissue-specific, B-MYB is broadly expressed in rapidly dividing cells of developing or adult mammals. B-MYBs liaisons with important players of the cell cycle and transcription machinery, such as E2F and retinoblastoma proteins, suggest that its essential function in stem cell formation and mammalian development could be related to its ability to directly or indirectly impinge on gene expression. Besides its role in the cell cycle, B-MYB has been shown to promote cell survival by activating antiapoptotic genes such as ApoJ/clusterin and BCL2. Here, we discuss how B-MYB could be implicated in tumourigenesis by regulating gene expression.

[1]  G. Lang,et al.  A transcriptional regulatory element in the coding sequence of the human Bcl‐2 gene , 2005, Immunology.

[2]  S. Ishii,et al.  Myb controls G2/M progression by inducing cyclin B expression in the Drosophila eye imaginal disc , 2002, The EMBO journal.

[3]  N. Copeland,et al.  Mouse A‐myb encodes a trans‐activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. , 1994, The EMBO journal.

[4]  M. Saville,et al.  Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator , 2001, Oncogene.

[5]  B. Calabretta,et al.  Requirement of B- myb Function for Survival and Differentiative Potential of Human Neuroblastoma Cells (*) , 1995, The Journal of Biological Chemistry.

[6]  K. Klempnauer,et al.  Phosphorylation and activation of B-Myb by cyclin A–Cdk2 , 1997, Current Biology.

[7]  T K Johnson,et al.  Phosphorylation of B-Myb Regulates Its Transactivation Potential and DNA Binding* , 1999, The Journal of Biological Chemistry.

[8]  P. Meltzer,et al.  Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  K. Klempnauer,et al.  Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCFp45Skp2 pathway , 2000, Oncogene.

[10]  D. Kioussis,et al.  Dominant interfering alleles define a role for c-Myb in T-cell development. , 1994, Genes & development.

[11]  J. Harper,et al.  A license to kill: transcriptional activation and enhanced turnover of Myc by the SCF(kp2) ubiquitin ligase. , 2003, Cancer cell.

[12]  John S. Satterlee,et al.  Native E2F/RBF Complexes Contain Myb-Interacting Proteins and Repress Transcription of Developmentally Controlled E2F Target Genes , 2004, Cell.

[13]  C. Peschle,et al.  Activation of human B-MYB by cyclins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Robert E. Lewis,et al.  PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites , 2001, Oncogene.

[15]  K. Klempnauer,et al.  The cooperation of B-Myb with the coactivator p300 is orchestrated by cyclins A and D1 , 2004, Oncogene.

[16]  K. Rajewsky,et al.  Critical functions for c-Myb at three checkpoints during thymocyte development , 2004, Nature Immunology.

[17]  Y. Chen,et al.  Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. , 2000, Cancer research.

[18]  M. Botchan,et al.  Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex. , 2004, Genes & development.

[19]  S. Ishii,et al.  B-myb Is Required for Inner Cell Mass Formation at an Early Stage of Development* , 1999, The Journal of Biological Chemistry.

[20]  G. Anderson,et al.  Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c‐Myb , 2003, The EMBO journal.

[21]  S. Swerdlow,et al.  A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis , 1991, Cell.

[22]  C. Peschle,et al.  The Retinoblastoma Family Member p107 Binds to B-MYB and Suppresses Its Autoregulatory Activity* , 1996, The Journal of Biological Chemistry.

[23]  T. Crook,et al.  HPV16 E7 oncoprotein deregulates B‐myb expression: correlation with targeting of p107/E2F complexes. , 1994, The EMBO journal.

[24]  E. Lam,et al.  Cell-cycle regulation of human B-myb transcription. , 1995, Gene.

[25]  G. Ramsay,et al.  Mutations in Drosophila myb lead to centrosome amplification and genomic instability. , 2002, Development.

[26]  E. Reddy,et al.  The myb gene family in cell growth, differentiation and apoptosis , 1999, Oncogene.

[27]  K. Klempnauer,et al.  Regulation of B-Myb activity by cyclin D1 , 2000, Oncogene.

[28]  Robert E. Lewis,et al.  Effects of B-Myb on Gene Transcription , 2002, The Journal of Biological Chemistry.

[29]  C. Franceschi,et al.  Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction. , 1999, Cancer research.

[30]  C. Peschle,et al.  Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53. , 1996, Cancer research.

[31]  G. Pagnan,et al.  DNA damage or growth factor withdrawal does not evoke activation of MYB transcription factors in neuronal cancer cell lines , 2003, Neuroscience Letters.

[32]  B. Calabretta,et al.  Direct Transactivation of the Anti-apoptotic Gene Apolipoprotein J (Clusterin) by B-MYB* , 2000, The Journal of Biological Chemistry.

[33]  G. Tonini,et al.  Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification. , 1999, Cancer research.

[34]  T. Graf,et al.  v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. , 1996, Genes & development.

[35]  Pasquale De Luca,et al.  B-MYB transactivates its own promoter through SP1-binding sites , 1999, Oncogene.

[36]  H. van Dekken,et al.  Molecular cytogenetic evaluation of virus‐associated and non‐viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias , 2000 .

[37]  A. Toscani,et al.  Arrest of spermatogenesis and defective breast development in mice lacking A-myb , 1997, Nature.

[38]  L. Greene,et al.  Regulation of Neuronal Survival and Death by E2F-Dependent Gene Repression and Derepression , 2001, Neuron.

[39]  K. Klempnauer,et al.  Expression of B-Myb during mouse embryogenesis. , 1996, Oncogene.

[40]  Shiaw-Yih Lin,et al.  Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction , 1996, Molecular and cellular biology.

[41]  B. Aronow,et al.  Temperature-dependent Modification and Activation of B-MYB , 2005, Journal of Biological Chemistry.

[42]  W. Sellers,et al.  Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. , 2002, Cancer research.

[43]  L. Wolff,et al.  Acceleration of apoptosis in transforming growth factor beta 1-treated M1 cells ectopically expressing B-myb. , 1995, Cancer research.

[44]  S. Whittaker,et al.  Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. , 2003, Blood.

[45]  J. Nevins,et al.  E2Fs link the control of G1/S and G2/M transcription , 2004, The EMBO journal.

[46]  D. McDonnell,et al.  The Transcription Factor B-Myb Is Maintained in an Inhibited State in Target Cells through Its Interaction with the Nuclear Corepressors N-CoR and SMRT , 2002, Molecular and Cellular Biology.

[47]  E. Reddy,et al.  Requirement of c-myb in T cell development and in mature T cell function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Watson,et al.  The Cell Cycle-regulated B-Myb Transcription Factor Overcomes Cyclin-dependent Kinase Inhibitory Activity of p57KIP2 by Interacting with Its Cyclin-binding Domain* , 2003, Journal of Biological Chemistry.

[49]  E. Wintersberger,et al.  Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F , 1996, Molecular and cellular biology.

[50]  B. Calabretta,et al.  Expression of Insulin-like Growth Factor-binding Protein 5 in Neuroblastoma Cells Is Regulated at the Transcriptional Level by c-Myb and B-Myb via Direct and Indirect Mechanisms* , 2002, The Journal of Biological Chemistry.

[51]  Dong-Hoon Shin,et al.  Constitutive expression of c-myb mRNA in the adult rat brain , 2001, Brain Research.

[52]  R. Ramsay,et al.  c-Myb is critical for murine colon development , 1999, Oncogene.

[53]  C. Franceschi,et al.  Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[54]  L. Herzenberg,et al.  Functional Evolution of the Vertebrate Myb Gene Family , 2005, Genetics.

[55]  E. Lam,et al.  Characterization and cell cycle-regulated expression of mouse B-myb. , 1992, Oncogene.

[56]  K. Nakayama,et al.  The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. , 2003, Molecular cell.

[57]  M. Saville,et al.  B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107 , 2002, Oncogene.

[58]  R. Watson,et al.  Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle. , 1996, Oncogene.

[59]  L. Greene,et al.  B-Myb and C-Myb Play Required Roles in Neuronal Apoptosis Evoked by Nerve Growth Factor Deprivation and DNA Damage , 2004, The Journal of Neuroscience.

[60]  R. Watson,et al.  B‐Myb protein in cellular proliferation, transcription control, and cancer: Latest developments , 1999, Journal of cellular physiology.

[61]  K. Weston,et al.  A dominant interfering Myb mutant causes apoptosis in T cells. , 1996, Genes & development.